159 related articles for article (PubMed ID: 22319069)
21. Late outcomes after drug-eluting stent implantation in "real-world" clinical practice.
Ramsdale DR; Rao A; Asghar O; Ramsdale KA; McKay E
J Invasive Cardiol; 2008 Oct; 20(10):493-500. PubMed ID: 18829991
[TBL] [Abstract][Full Text] [Related]
22. Incidence and predictors of recurrent restenosis following implantation of drug-eluting stents for in-stent restenosis.
Lee CW; Park CB; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
Catheter Cardiovasc Interv; 2007 Jan; 69(1):104-8. PubMed ID: 17139669
[TBL] [Abstract][Full Text] [Related]
23. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
[TBL] [Abstract][Full Text] [Related]
24. Resistant in-stent restenosis in the drug eluting stent era.
Theodoropoulos K; Mennuni MG; Dangas GD; Meelu OA; Bansilal S; Baber U; Sartori S; Kovacic JC; Moreno PR; Sharma SK; Mehran R; Kini AS
Catheter Cardiovasc Interv; 2016 Nov; 88(5):777-785. PubMed ID: 27184223
[TBL] [Abstract][Full Text] [Related]
25. Treatment of diffuse in-stent restenosis with drug-eluting stents vs. intracoronary beta-radiation therapy: INDEED Study.
Park SW; Lee SW; Koo BK; Park DW; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Mori K; Lansky AJ; Mintz GS; Lee MM; Park SJ
Int J Cardiol; 2008 Dec; 131(1):70-7. PubMed ID: 18190986
[TBL] [Abstract][Full Text] [Related]
26. Randomized comparison between intracoronary beta-radiation brachytherapy and implantation of paclitaxel-eluting stents for the treatment of diffuse in-stent restenosis.
Schukro C; Syeda B; Kirisits C; Schmid R; Pichler P; Pokrajac B; Lang I; Pötter R; Glogar D
Radiother Oncol; 2007 Jan; 82(1):18-23. PubMed ID: 16971011
[TBL] [Abstract][Full Text] [Related]
27. Comparison of effectiveness and safety of drug-eluting stents versus vascular brachytherapy for saphenous vein graft in-stent restenosis.
Mishra S; Wolfram RM; Torguson R; Chu WW; Xue Z; Gevorkian N; Donekal S; Chan R; Pichard AD; Satler LF; Kent KM; Waksman R
Am J Cardiol; 2006 May; 97(9):1303-7. PubMed ID: 16635600
[TBL] [Abstract][Full Text] [Related]
28. Comparison of sirolimus versus paclitaxel eluting stents for treatment of coronary in-stent restenosis.
Airoldi F; Briguori C; Iakovou I; Stankovic G; Biondi-Zoccai G; Carlino M; Chieffo A; Montorfano M; Cosgrave J; Michev I; Rogacka R; Sangiorgi GM; Colombo A
Am J Cardiol; 2006 Apr; 97(8):1182-7. PubMed ID: 16616023
[TBL] [Abstract][Full Text] [Related]
29. Everolimus-eluting versus paclitaxel-eluting stents for treatment of bare metal stent restenosis.
Almalla M; Schröder JW; Pross V; Stegemann E; Marx N; Hoffmann R
Am J Cardiol; 2011 Aug; 108(4):518-22. PubMed ID: 21624553
[TBL] [Abstract][Full Text] [Related]
30. Correlates of failure following treatment with Sr-90 beta irradiation for in-stent restenosis.
Almeda FQ; Chua DY; Nathan S; Kim S; Meyer PM; Nguyen C; Chu JC; Kavinsky CJ; Snell RJ; Schaer GL
Catheter Cardiovasc Interv; 2003 Jun; 59(2):176-83. PubMed ID: 12772235
[TBL] [Abstract][Full Text] [Related]
31. Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial.
Ellis SG; O'Shaughnessy CD; Martin SL; Kent K; McGarry T; Turco MA; Kereiakes DJ; Popma JJ; Friedman M; Koglin J; Stone GW;
Eur Heart J; 2008 Jul; 29(13):1625-34. PubMed ID: 18556716
[TBL] [Abstract][Full Text] [Related]
32. Restenosis treatment in the drug-eluting stent era.
Presbitero P; Boccuzzi G
Ital Heart J; 2005 Jun; 6(6):514-21. PubMed ID: 16008157
[TBL] [Abstract][Full Text] [Related]
33. Impact of "off-label" utilization of drug-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention.
Roy P; Buch AN; Javaid A; Okabe T; Raya V; Pinto Slottow TL; Steinberg DH; Smith K; Xue Z; Gevorkian N; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
Am J Cardiol; 2008 Feb; 101(3):293-9. PubMed ID: 18237587
[TBL] [Abstract][Full Text] [Related]
34. Everolimus- and zotarolimus-eluting stents for bare metal stent in-stent restenosis treatment: a prospective study.
Toutouzas K; Patsa C; Tsiamis E; Tsioufis C; Spanos A; Stefanadi E; Tentolouris C; Stefanadis C
J Interv Cardiol; 2008 Oct; 21(5):388-94. PubMed ID: 18705639
[TBL] [Abstract][Full Text] [Related]
35. Clinical outcomes of drug-eluting versus bare-metal in-stent restenosis.
Singh IM; Filby SJ; Sakr FE; Gorodeski EZ; Lincoff AM; Ellis SG; Shishehbor MH
Catheter Cardiovasc Interv; 2010 Feb; 75(3):338-42. PubMed ID: 19937786
[TBL] [Abstract][Full Text] [Related]
36. Target lesion revascularization after bare-metal or drug-eluting stents: clinical presentations and outcomes.
Hayes KR; Applegate RJ; Sacrinty MT; Kutcher MA; Gandhi SK; Santos RM; Little WC
J Invasive Cardiol; 2010 Jun; 22(6):266-70. PubMed ID: 20516505
[TBL] [Abstract][Full Text] [Related]
37. [Results of implantation of drug-eluting stents in extensive lesion of the coronary bed according to angiographic and intravascular ultrasound findings].
Cherkavskaia OV; Savchenko AP; Rudenko BA; Merkulov EV
Vestn Rentgenol Radiol; 2012; (2):14-9. PubMed ID: 22730754
[TBL] [Abstract][Full Text] [Related]
38. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
[TBL] [Abstract][Full Text] [Related]
39. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.
Stone GW; Lansky AJ; Pocock SJ; Gersh BJ; Dangas G; Wong SC; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Möckel M; Ochala A; Kellock A; Parise H; Mehran R;
N Engl J Med; 2009 May; 360(19):1946-59. PubMed ID: 19420364
[TBL] [Abstract][Full Text] [Related]
40. Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease: results from the Prairie "Real World" Stent Registry.
Goswami NJ; Gaffigan M; Berrio G; Plessa AL; Pfeiffer AM; Markwell SJ; Mishkel GJ
Catheter Cardiovasc Interv; 2010 Jan; 75(1):93-100. PubMed ID: 19787803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
